Related references
Note: Only part of the references are listed.Thiazolidinediones Reduce Pathological Neovascularization in Ischemic Retina Via an Adiponectin-Dependent Mechanism
Akiko Higuchi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
PPARγ Mediates a Direct Antiangiogenic Effect of ω3-PUFAs in Proliferative Retinopathy
Andreas Stahl et al.
CIRCULATION RESEARCH (2010)
PPARγ in Placental Angiogenesis
Karim Nadra et al.
ENDOCRINOLOGY (2010)
Glitazone Use Associated with Diabetic Macular Edema
Donald S. Fong et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
Peroxisome proliferator-activated receptor β stimulation induces rapid cardiac growth and angiogenesis via direct activation of calcineurin
Nicole Wagner et al.
CARDIOVASCULAR RESEARCH (2009)
Identification of a Physiologically Relevant Endogenous Ligand for PPARα in Liver
Manu V. Chakravarthy et al.
CELL (2009)
Fibrates and Microvascular Complications in Diabetes - Insight from the FIELD Study
J. C. Ansquer et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Pharmacological activation of PPARβ promotes rapid and calcineurin-dependent fiber remodeling and angiogenesis in mouse skeletal muscle
Celine Gaudel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
PPARγ ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis
Ahmad Aljada et al.
ANGIOGENESIS (2008)
Rosiglitazone and delayed onset of proliferative diabetic retinopathy
Lucy Q. Shen et al.
ARCHIVES OF OPHTHALMOLOGY (2008)
Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice
Po-Hsun Huang et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
AMPK and PPARδ Agonists are exercise mimetics
Vihang A. Narkar et al.
CELL (2008)
Selective activation of peroxisome proliferator-activated receptor (PPAR)α and PPARγ induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism
Federico Biscetti et al.
DIABETES (2008)
PPARα agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition
Dipak Panigrahy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Deregulation of tumor angiogenesis and blockade of tumor growth in PPARβ-deficient mice
Sabine Mueller-Bruesselbach et al.
EMBO JOURNAL (2007)
Transcriptional network governing the angiogenic, switch in human pancreatic cancer
Amir Abdollahi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Evolution of peroxisome proliferator-activated receptor agonists
Feng Chang et al.
ANNALS OF PHARMACOTHERAPY (2007)
PPAR-γ agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts
Vishnu Chintalgattu et al.
CARDIOVASCULAR RESEARCH (2007)
Proteomic profile of mouse fibroblasts with a targeted disruption of the peroxisome proliferator activated receptor-β/δ gene
Juergen Adamkiewicz et al.
PROTEOMICS (2007)
Activation of PPAR beta/delta induces endothelial cell proliferation and angiogenesis
Laura Piqueras et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors
Liliane Michalik et al.
PHARMACOLOGICAL REVIEWS (2006)
Efficacy of peroxisome proliferative activated receptor (PPAR)-α ligands, fenofibrate, on intimal hyperplasia and constrictive remodeling after coronary angioplasty in porcine models
Takatoshi Kasai et al.
ATHEROSCLEROSIS (2006)
Oxidized LDL binding to LOX-1 upregulates VEGF expression in cultured bovine chondrocytes through activation of PPAR-γ
Sohya Kanata et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Peroxisome proliferator-activated receptor-γ-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia
Kon Chu et al.
BRAIN RESEARCH (2006)
Proteomic analysis of vascular endothelial growth factor-induced endothelial cell differentiation reveals a role for chloride intracellular channel 4 (CLIC4) in tubular morphogenesis
S Bohman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-γ ligand
MA Sarayba et al.
EXPERIMENTAL EYE RESEARCH (2005)
PPAR delta: an uncompletely known nuclear receptor
A Fredenrich et al.
DIABETES & METABOLISM (2005)
Antineoplastic effects of peroxisome proliferator-activated receptor γ agonists
C Grommes et al.
LANCET ONCOLOGY (2004)
Regulation of muscle fiber type and running endurance by PPARδ
YX Wang et al.
PLOS BIOLOGY (2004)
Activation of peroxisome proliferator-activated receptor δ stimulates the proliferation of human breast and prostate cancer cell lines
RL Stephen et al.
CANCER RESEARCH (2004)
Bifunctional properties of peroxisome proliferator-activated receptor γ 1 in KDR gene regulation mediated via interaction with both Sp1 and Sp3
Y Sassa et al.
DIABETES (2004)
Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation
D Bishop-Bailey et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2003)
Fenofibrate inhibits angiogenesis in vitro and in vivo
J Varet et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
CRBP suppresses breast cancer cell survival and anchorage-independent growth
YS Kuppumbatti et al.
ONCOGENE (2001)
Peroxisome proliferator-activated receptor-γ agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells
K Yamakawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Peroxisome proliferator-activated receptors in the cardiovascular system
D Bishop-Bailey
BRITISH JOURNAL OF PHARMACOLOGY (2000)